NCT06880432View on ClinicalTrials.gov

Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Cohort of Adult Obese Patients and Longitudinal Follow-up

NANot yet recruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

December 31, 2039

Study Completion Date

December 31, 2039

Conditions
Obesity and Overweight
Interventions
OTHER

Collection of fluid samples

\- Blood sampling, urine sampling and tissue sampling

Trial Locations (1)

Unknown

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT06880432 - Sarcopenic Obesity: Estimation of Prevalence and Identification of Clinical and Biological Determinants in a Cohort of Adult Obese Patients and Longitudinal Follow-up | Biotech Hunter | Biotech Hunter